UCB Pharma, Inc. : Growing Demand From Epilepsy Patients for Seizure Response Dogs Answered by Partnership Between UCB Pharma, Inc. and Canine Assistants
1st Nov 2005, 17:05 GMT
ATLANTA, GA (MARKET WIRE) UCB Pharma, Inc., and Canine Assistants today announced a multi-year partnership to sponsor seizure response dogs for epilepsy patients across the U.S. These dogs represent the fastest growing requests received by Canine Assistants. Under the sponsorship, UCB will provide support for the care, training and lifetime veterinary costs of all dogs given to epilepsy patients.
UCB Pharma, Inc. : Growing Demand From Epilepsy Patients for Seizure Response Dogs Answered by Partnership Between UCB Pharma, Inc. and Canine Assistants related news:
- Growing Demand from Epilepsy Patients for Seizure Response Dogs Answered by Partnership between UCB Pharma and Canine Assistants — Partnerships/ Joint Ventures News from StratCenter.com
- Growing Demand from Epilepsy Patients for Seizure Response Dogs Answered by Partnership between UCB Pharma, Inc. and Canine Assistants — PR Newswire: All Releases
- PA Department of Health: State Invests $750,000 for Statewide Programs Increasing Awareness of Seizure DisordersFunding announced as part of Epilepsy Awareness Month — mysan.de
- Halloween Has Gone to the Dogs! — Paper Weblog
- Better understanding of T cell response — News-Medical News Feed
- PDL lands $10M under expanded Roche partnership — Latest news from East Bay Business Times
- NovaDel Pharma Inc. To Present at Rodman and Renshaw Techvest 7th Annual Health Care Conference — Rednova News - Health
- DBS Trading aligns with KVD Pharma — Partnerships/ Joint Ventures News from StratCenter.com
- Touching tales in 'Found Dogs' — Accent
- American Pharma Reports Abraxane Data — Mammography News from StratCenter.com
Latest news from Market Wire - Medical and Healthcare:
- slp3D: ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Precise Biometrics AB: Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Lenstec, Inc.: Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL
- Takeda Pharmaceuticals North America: New Data Show ACTOS(R) (pioglitazone HCl) Halted Progression of Atherosclerosis as Indicated by CIMT in Patients With Type 2 Diabetes
- Dairy Fresh Farms Inc.: Dairy Fresh Farms Announces It Has Signed a Licensing Deal With NutriOne for the Canadian Market
- OTSP: Study to Be Published in JAMA: Diabetes Drug ACTOS(R) (pioglitazone HCl) Halted Progression of Key Marker for Atherosclerosis; Improvements Indicated by Carotid Intima-Media Thickness (CIMT)
- Vue Technology: Vue Technology Introduces First UHF Solution for Item-Level Visibility in the Retail Pharmacy; New RFID Solution Tracks Liquids, Pill Bottles, Blister Packs and Gels
- Union Dental Holdings, Inc.: Union Dental Signs Contract to Provide Dental Network for United Association of Plumbers and Pipefitters
- MEDSEEK: MEDSEEK, SelfCareNet, & Primetime Medical Partner to Deliver Integrated Consumer-Centric Solution
- Ridgecrest Healthcare Group, Inc.: Ridgecrest Healthcare Group to Acquire NOBO List